XTRA:SHLMedical Equipment
Siemens Healthineers (XTRA:SHL) Valuation Check After New Oncology And AI Diagnostics Moves
Siemens Healthineers (XTRA:SHL) is back in focus after two oncology focused moves: a supply agreement for Fluorine-18 radiolabelled RAD101 in a Phase 3 brain metastases trial and new funding support for ScreenPoint Medical’s breast cancer AI platform.
See our latest analysis for Siemens Healthineers.
These oncology moves come as the share price trades at €38.91, with a 1 month share price return of 6.46% after a weaker 90 day period, while the 1 year total shareholder return decline of 10.78%...